Company Co-Diagnostics, Inc.

Equities

CODX

US1897631057

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
1.14 USD 0.00% Intraday chart for Co-Diagnostics, Inc. -1.72% -14.29%

Business Summary

Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.

Number of employees: 155

Sales per Business

USD in Million2022Weight2023Weight Delta
Diagnostics Technologies
100.0 %
34 100.0 % 7 100.0 % -80.09%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
95.1 %
25 72.1 % 6 95.1 % -73.73%
Rest of World
4.9 %
10 27.9 % 0 4.9 % -96.52%

Managers

Managers TitleAgeSince
Chief Executive Officer 70 13-04-17
Director of Finance/CFO 48 21-02-21
Chief Tech/Sci/R&D Officer - 22-10-31
Investor Relations Contact - -
General Counsel - 23-08-28
General Counsel 77 14-10-31

Members of the board

Members of the board TitleAgeSince
General Counsel 77 14-10-31
Director/Board Member 79 17-04-30
Chief Executive Officer 70 13-04-17
Director/Board Member 71 19-08-29
Director/Board Member 54 19-06-24
Director/Board Member 64 19-06-24

Shareholders

NameEquities%Valuation
Vanguard Global Advisers LLC
5.698 %
1,781,283 5.698 % 2 M $
Richard Abbott
2.702 %
844,509 2.702 % 945 850 $
Renaissance Technologies LLC
1.974 %
617,000 1.974 % 691 040 $
BlackRock Institutional Trust Co. NA
1.588 %
496,526 1.588 % 556 109 $
Geode Capital Management LLC
0.9419 %
294,422 0.9419 % 329 753 $
Bridgeway Capital Management LLC
0.8730 %
272,900 0.8730 % 305 648 $
Dwight Egan
0.8666 %
270,881 0.8666 % 303 387 $
Brian Brown
0.6821 %
213,220 0.6821 % 238 806 $
Degroof Petercam Asset Services SA
0.5822 %
182,000 0.5822 % 203 840 $
The Bank of New York Mellon (New York)
0.4658 %
145,621 0.4658 % 163 096 $

Company contact information

Co-Diagnostics, Inc.

2401 South Foothill Drive Suite D

84109, Salt Lake City

+(801) 438-1036

http://www.codiagnostics.com
address Co-Diagnostics, Inc.(CODX)
  1. Stock Market
  2. Equities
  3. CODX Stock
  4. Company Co-Diagnostics, Inc.